The global predictivegenetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025,
according to a new report by Grand View Research, Inc. Key drivers attributing
to the market expansion include rising awareness pertaining to the use of
genomic tests for the prediction of gene susceptibility for probability of
disease development. Genetic data in the ecosystem increases when consumers buy
direct-to-consumer genomics products or participate in clinical research
trials.
Rising encouragement for the
use of these products is anticipated to propel industrial growth. Expansion in
the range of consumer genetic tests by market entities is anticipated to fuel
progress in the market in the coming years. Introduction of novel platforms
anticipates the DNA-powered applications thus rising market penetration.
Moreover, the pharmaceutical
companies are also engaged in partnerships with genomics companies in order to
develop novel therapeutics on the basis of genotypic and phenotypic
correlations. For instance, in April 2016 a ten-year deal was signed between Human
Longevity Inc. (HLI) and AstraZeneca, in which HLI is supposed to sequence
500,000 genomes of the clinical trial population of AstraZeneca. This data is
to be used for the identification of novel drug targets. The deal also provides
AstraZeneca with access to the proprietary knowledgebase in order augment
biomarker discovery, and facilitate drug development.
Access Full Research
Report On Predictive Genetic Testing & Consumer/Wellness
Genomics Market Analysis:
www.grandviewresearch.com/industry-analysis/predictive-genetic-testing-consumer-wellness-genomics-market
www.grandviewresearch.com/industry-analysis/predictive-genetic-testing-consumer-wellness-genomics-market
Further Key Findings from the Study Suggest:
·
Application of genetic
susceptibility tests in gynecology and endocrinology, is of great interest
thereby resulting to higher adoption.
·
These tests enable the
identification of the susceptibility of genes towards postmenopausal
osteoporosis, adenomyosis, and endometriosis.
·
Breast & ovarian cancer
based predictive testing accounted for the largest share owing to the rising
use of susceptibility testing for BRCA mutations cancer prediction.
·
Government and pertinent
organizations are engaged in endeavors aimed at curbing cancer-related
healthcare expenditure by encouraging patients to undergo regular diagnostic
examinations.
·
CRC screening initiatives
undertaken by the governments and implementation of mass CRC screening programs
is expected to increase the demand for CRC screening tests.
·
Asia Pacific is anticipated to
witness substantial growth in the coming years owing to accelerated uptake of
these predictive tests in the developing economies of this region.
·
Key players contributing in
this market are BGI, Illumina, Inc, Pathway Genomics, Genesis Genetics,
23andMe, Inc, ARUP Laboratories, Color Genomics Inc., and Myriad Genetics, Inc.
·
These entities are involved in
collaborations in order to develop their portfolio with respect to fragmented
point-solutions across the genomics value chain.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the
predictive genetic testing & consumer/wellness genomics market on the basis
of test type, application, and region:
Test Type Outlook (Revenue, USD
Million, 2013-2025)
·
Predictive Testing
o
Genetic Susceptibility Test
o
Predictive Diagnostics
o
Population Screening
·
Consumer Genomics
·
Wellness Genomics
Application Outlook (Revenue,
USD Million, 2013-2025)
·
Predictive Genetic Testing
& Consumer Genomics
o
Breast & Ovarian Cancer
o
Cardiovascular screening
o
Diabetic Screening &
Monitoring
o
Colon Cancer
o
Parkinsonism / Alzheimer’s
Disease
o
Urologic screening/ Prostate
cancer screening
o
Orthopedic &
Musculoskeletal
o
Other cancer screening
o
Other diseases
·
Wellness Genomics
o
Nutria Genetics
o
Skin & Metabolism Genetics
o
Others
Regional Outlook (Revenue, USD
Million, 2013-2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
o
Australia
o
India
o
Singapore
·
Latin America
o
Brazil
·
Middle East and Africa (MEA)
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-predictive-genetic-testing-consumer-wellness-genomics-market
www.grandviewresearch.com/press-release/global-predictive-genetic-testing-consumer-wellness-genomics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
